Table 3.
Characteristics of 40–64-year-old study populations involved in the calculation of SCORE, PCE and, RPCE by ethnicity and sex.
| Males | Females | |||||
|---|---|---|---|---|---|---|
| Hungarian general (n = 96) | Hungarian Roma (n = 52) | p-value | Hungarian general (n = 127) | Hungarian Roma (n = 145) | p-value | |
| Mean (95% CI) | Mean (95% CI) | |||||
| Age (years) | 51.36 (50.02–52.71) | 52.69 (50.69–54.70) | 0.292 | 51.02 (49.81–52.24) | 50.24 (49.14–51.35) | 0.354 |
| Total cholesterol levels (mmol/L) | 5.21 (5.00–5.41) | 5.12 (4.82–5.41) | 0.476 | 5.22 (5.04–5.40) | 5.31 (5.13–5.50) | 0.613 |
| HDL-C levels (mmol/L) | 1.33 (1.25–1.41) | 1.25 (1.14–1.35) | 0.212 | 1.48 (1.41–1.55) | 1.31 (1.25–1.37) | < 0.001 |
| Systolic blood pressure (mmHg) | 131.06 (128.51–133.61) | 133.08 (127.19–138.52) | 0.981 | 127.19 (124.69–129.70) | 128.73 (125.88–131.58) | 0.967 |
| Prevalence (%) | p-value | Prevalence (%) | p-value | |||
|---|---|---|---|---|---|---|
| Smokers | 35.42 (26.40–45.30) | 57.69 (44.15–70.40) | 0.009 | 36.22 (28.25–44.81) | 65.52 (57.53–72.89) | < 0.001 |
| Treated for high blood pressurea | 30.21 (21.71–39.88) | 48.46 (26.15–52.02) | 0.308 | 37.01 (28.98–45.62) | 40.69 (32.94–48.80) | 0.534 |
| Diabetesa | 12.50 (7.02–20.20) | 11.54 (4.96–22.24) | 0.864 | 11.02 (6.46–17.34) | 18.62 (12.94–25.54) | 0.081 |
| Receiving lipid-lowering therapyb | 6.25 (2.65–12.43) | 15.38 (7.55–26.94) | 0.069 | 6.30 (3.02–11.53) | 14.48 (9.48–20.89) | 0.029 |
Significant differences in mean or prevalence rates are highlighted in bold.
aNot used for SCORE chart calculation.
bNot used for risk calculation in any risk assessment models.